健康
Trending

Global Digital Respiratory Solutions Market 2020-2030

Product Type, Indication (Asthma, COPD), Distribution Channel, and Region: Trend Forecast and Growth Opportunity

Global digital respiratory solutions market will reach $319.3 million by 2030, growing by 36.2% annually over 2020-2030 driven by the rising demand for air filtration amid COVID-19 pandemic.

Highlighted with 84 tables and 76 figures, this 164-page report “Global Digital Respiratory Solutions Market 2020-2030 by Product Type, Indication (Asthma, COPD), Distribution Channel, and Region: Trend Forecast and Growth Opportunity” is based on comprehensive research of the entire global digital respiratory solutions market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2015-2019 and provides forecast from 2020 till 2030 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:

• Market Structure

• Growth Drivers

• Restraints and Challenges

• Emerging Product Trends & Market Opportunities

• Porter’s Fiver Forces

The trend and outlook of global market are forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global digital respiratory solutions market in every aspect of the classification from perspectives of Product Type, Indication, Distribution Channel, and Region.

 

Based on Product Type, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.

Therapeutic Devices

• Inhalers

• Nebulizers

Diagnostic Devices

• Spirometers

• Asthma Monitors

• Other Diagnostic Devices

Sensors and Apps

 

Based on Indication, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.

• Asthma

• Chronic Obstructive Pulmonary Disease (COPD)

• COVID-19 Caused Diseases

• Other Diseases

 

Based on Distribution Channel, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.

• Hospital Pharmacies

• Retail Pharmacies

• Online Pharmacies

 

Geographically, the following regions together with the listed national/local markets are fully investigated:

• APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, and Sri Lanka)

• Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Belgium, Denmark, Austria, Norway, Sweden, The Netherlands, Poland, Czech Republic, Slovakia, Hungary, and Romania)

• North America (U.S., Canada, and Mexico)

• South America (Brazil, Chile, Argentina, Rest of South America)

• RoW (Saudi Arabia, UAE, South Africa)

For each aforementioned region and country, detailed analysis and data for annual revenue are available for 2019-2030. The breakdown of all regional markets by country and split of key national markets by Product Type, Indication, and Distribution Channel over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Specifically, potential risks associated with investing in global digital respiratory solutions market are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.

Key Players (this may not be a complete list and extra companies can be added upon request):

3M Health Care Limited

Adherium Limited

Amiko Digital Health Limited

AsthmaMD

AstraZeneca plc

Boehringer Ingelheim International GmbH

Capsule Technologies, Inc.

Cohero Health

GlaxoSmithKline plc

Kaia Health Software GmbH

Medical International Research (MIR)

Novartis AG

NuvoAir

Reciprocal Labs (Propeller Health)

Sensiron AG

Tactio Health

Teva Pharmaceuticals Industries Ltd.

Download Free Sample: https://thepiresearch.com/research-report/1631

1 Introduction 8

1.1 Industry Definition and Research Scope 8

1.1.1 Industry Definition 8

1.1.2 Research Scope 9

1.2 Research Methodology 12

1.2.1 Overview of Market Research Methodology 12

1.2.2 Market Assumption 13

1.2.3 Secondary Data 13

1.2.4 Primary Data 13

1.2.5 Data Filtration and Model Design 15

1.2.6 Market Size/Share Estimation 16

1.2.7 Research Limitations 17

1.3 Executive Summary 18

2 Market Overview and Dynamics 20

2.1 Market Size and Forecast 20

2.1.1 Impact of COVID-19 on the Market 21

2.2 Major Growth Drivers 23

2.3 Market Restraints and Challenges 28

2.4 Emerging Opportunities and Market Trends 31

2.5 Porter’s Fiver Forces Analysis 35

3 Segmentation of Global Market by Product Type 40

3.1 Market Overview by Product Type 40

3.2 Therapeutic Devices 42

3.2.1 Inhalers 43

3.2.2 Nebulizers 44

3.3 Diagnostic Devices 45

3.3.1 Spirometers 47

3.3.2 Asthma Monitors 48

3.3.3 Other Diagnostic Devices 49

3.4 Sensors and Apps 50

4 Segmentation of Global Market by Indication 51

4.1 Market Overview by Indication 51

4.2 Asthma 53

4.3 Chronic Obstructive Pulmonary Disease (COPD) 54

4.4 COVID-19 Caused Diseases 55

4.5 Other Diseases 56

5 Segmentation of Global Market by Distribution Channel 57

5.1 Market Overview by Distribution Channel 57

5.2 Hospital Pharmacies 59

5.3 Retail Pharmacies 60

5.4 Online Pharmacies 61

6 Segmentation of Global Market by Region 62

6.1 Geographic Market Overview 2019-2030 62

6.2 North America Market 2019-2030 by Country 68

6.2.1 Overview of North America Market 68

6.2.2 U.S. 72

6.2.3 Canada 76

6.2.4 Mexico 78

6.3 European Market 2019-2030 by Country 80

6.3.1 Overview of European Market 80

6.3.2 Germany 84

6.3.3 UK 86

6.3.4 France 88

6.3.5 Spain 90

6.3.6 Italy 92

6.3.7 Russia 94

6.3.8 Rest of European Market 96

6.4 Asia-Pacific Market 2019-2030 by Country 98

6.4.1 Overview of Asia-Pacific Market 98

6.4.2 Japan 102

6.4.3 China 105

6.4.4 Australia 108

6.4.5 India 110

6.4.6 South Korea 112

6.4.7 Rest of APAC Region 114

6.5 South America Market 2019-2030 by Country 116

6.5.1 Argentina 119

6.5.2 Brazil 121

6.5.3 Chile 123

6.5.4 Rest of South America Market 125

6.6 MEA Market 2019-2030 by Country 126

6.6.1 UAE 129

6.6.2 Saudi Arabia 131

6.6.3 South Africa 133

6.6.4 Other National Markets 135

7 Competitive Landscape 136

7.1 Overview of Key Vendors 136

7.2 New Product Launch, Partnership, Investment, and M&A 139

7.3 Company Profiles 140

3M Health Care Limited 140

Adherium Limited 142

Amiko Digital Health Limited 143

AsthmaMD 144

AstraZeneca plc 145

Boehringer Ingelheim International GmbH 146

Capsule Technologies, Inc. 147

Cohero Health 148

GlaxoSmithKline plc 149

Kaia Health Software GmbH 150

Medical International Research (MIR) 151

Novartis AG 152

NuvoAir 153

Reciprocal Labs (Propeller Health) 154

Sensiron AG 155

Tactio Health 156

Teva Pharmaceuticals Industries Ltd. 157

8 Investing in Global Market: Risk Assessment and Management 158

8.1 Risk Evaluation of Global Market 158

8.2 Critical Success Factors (CSFs) 161

Related Reports and Products 164

Buy Report : https://thepiresearch.com/research-report/1631

Contact Anna – info@thepiresearch.com

Tags

Related Articles

Close